Popular on TelAve
- FirstFruits Farms and Opal Partner with the Junior Basketball League to Empower Youth Through Nutrition and Sport
- Peachtree Immediate Care Opens Two New Locations in December
- Webinar Announcement: Navigating the New Investment Adviser AML Mandate: What Steps Should Investment Advisers Be Taking Now?
- Industry-Changing Multi-Benefit Service Platform for Technology Systems & AI Smart Devices Drives; 218% Revenue Growth for Tekumo: Stock Symbol: TKMO
- Somebody's Husband by Robbi Renee Earns Early Acclaim for Its Powerful Exploration of Love, Loss, and Healing
- OmegaBrand Introduces New Thermal Transfer Ribbons for Honeywell PC45t Printers
- Texas Center For Oral Surgery & Dental Implants Launches Redesigned Website to Enhance Patient Experience
- New Age of Law Firm Website Design
- New Drug Application to the FDA for the Treatment of Suicidal Depression that Affects 13+ Million Americans Each Year: NRx Pharma: Stock Symbol:NRXP
- Stan Fitzgerald: A Profile in Resilience and Leadership with VFAF Veterans for America First Organizational Support for a Presidential Pardon
Similar on TelAve
- Dr. Lauren Anderson Led a Successful CE Event: Digital Planning and Execution
- Latest Updates to Pennsylvania Medical Malpractice and Birth Injury Law
- CCHR Cites Newly Released Mind Control Records to Oppose Psychedelics
- Investor Workshop at Mar-A-Lago, $27 Million for Acquisitions and Drug Treatment of Suicidal Depression: NRx Pharmaceuticals, Inc. (Stock S: NRXP)
- The Dental Specialists in Newton, MA, Introduces Cutting-Edge 3Shape TRIOS 5 Intraoral Scanner
- Agreement for $27 Million in Funding for Expanding Clinic Acquisitions and Operations,: NRx Pharmaceuticals, Inc. Stock Symbol: NRXP)
- Watchdog Reviews Milestones in Exposing Psychiatric Human Rights Abuses in 2024
- Acmeware and Interlace Health Join Forces to Revolutionize Downtime Solutions
- Acquisition of Kadima Neuropsychiatry Institute for CNS & Psychedelic Research Planned; New Drug Application for Suicidal Depression Treatment: $NRXP
- New Drug Application to the FDA for the Treatment of Suicidal Depression that Affects 13+ Million Americans Each Year: NRx Pharma: Stock Symbol:NRXP
Thyroid Nodule Treatment Center Announces Thyroid Nodule CellFX nsPFA treatment by Dr. Harding
TelAve News/10850795
By introducing state-of-the-art CellFX nsPFA alongside thyroid nodule RFA treatment, Dr. Harding offers the most advanced minimally invasive, non-surgical procedures for treating thyroid nodules, eliminating the need for a lifetime of medication.
PHOENIX - TelAve -- The Thyroid Nodule Treatment Center is proud to announce the availability of Thyroid Nodule CellFX nsPFA (nano-Second Pulsed Field Ablation) treatment. As a pioneering endocrine surgeon, Dr. Harding is dedicated to offering state-of-the-art treatments to patients suffering from thyroid nodules without requiring surgery. The new CellFX nsPFA technology utilizes ultra-short electric pulses to precisely target and eliminate abnormal thyroid nodule cells, while preserving the surrounding healthy tissue, providing a minimally invasive and highly effective treatment option.
Dr. Harding's decision to include CellFX nsPFA (nano-Second Pulsed Field Ablation) technology in addition to Thyroid Nodule Radiofrequency Ablation (RFA) into his practice reflects his unwavering commitment to providing the most advanced and effective treatment options for patients with thyroid nodules.
More on TelAve News
"I am thrilled to offer CellFX nsPFA as a new treatment option for our patients," said Dr. Richard Harding. "Nanosecond Pulsed Field Ablation, or nsPFA, has many benefits for patients. It is safe, fast and enables a rapid, natural process for clearing unwanted cellular tissue resulting in a gentle and comfortable treatment experience for my patients."
For more information or to schedule a consultation with Dr. Richard Harding, please contact the Thyroid Nodule Treatment Center at (602) 889-2923 or visit https://www.thyroidnoduletreatment.com
2320 N. Third Street
Phoenix, AZ 85004
https://youtu.be/8Ro5jA3WQFQ?si=rzZsklsxWIsplgsS
About the Thyroid Nodule Treatment Center:
The Thyroid Nodule Treatment Center, located in Phoenix, Arizona, specializes in the diagnosis and treatment of thyroid nodules. The mission of the Thyroid Nodule Treatment Center (TNTC) is the preservation of normal thyroid function while treating benign symptomatic thyroid nodules using the most advanced minimally invasive treatments available. Under the expert leadership of Dr. Richard Harding, the center is committed to providing patients with the latest and most effective treatment options in a compassionate and supportive environment.
More on TelAve News
https://thyroidnoduletreatment.center
About Dr. Richard Harding
Dr. Richard Harding treats benign symptomatic thyroid nodules using the most advance minimally invasive treatments available. Richard J. Harding, MD, FACS is the most experienced thyroid surgeon in Arizona and has been voted Top Doctor by Phoenix Magazine. He has also been awarded Surgeon of Excellence in Robotic Surgery. He has been on the forefront of surgical advances for truly scar-less surgery with his introduction of Transoral Endoscopic Thyroidectomy Vestibular Approach, the radiofrequency ablation (RFA) of benign thyroid nodules, and now CellFX nsPFA (nano-Second Pulsed Field Ablation) treatment at his state of the art facility in Phoenix, Arizona.
Dr. Harding's decision to include CellFX nsPFA (nano-Second Pulsed Field Ablation) technology in addition to Thyroid Nodule Radiofrequency Ablation (RFA) into his practice reflects his unwavering commitment to providing the most advanced and effective treatment options for patients with thyroid nodules.
More on TelAve News
- Orcas Island Property Owner Returns Two Prime Waterfront Properties to the Market
- Muench Workshops Welcomes New Partners Luke Dray and Sara Linssen, Announces Retirement of Andy Williams
- NuNorm Announces Stop Soldier Suicide as This Year's EQUAL Grant Recipient
- Darrin Jones: The Creative Force Behind the Trends—Raising Questions About Influence in The Weeknd's Music
- Foresight Practitioner Conference 2025 – Dates, Venue, Speakers, And Competition Finalists Announced
"I am thrilled to offer CellFX nsPFA as a new treatment option for our patients," said Dr. Richard Harding. "Nanosecond Pulsed Field Ablation, or nsPFA, has many benefits for patients. It is safe, fast and enables a rapid, natural process for clearing unwanted cellular tissue resulting in a gentle and comfortable treatment experience for my patients."
For more information or to schedule a consultation with Dr. Richard Harding, please contact the Thyroid Nodule Treatment Center at (602) 889-2923 or visit https://www.thyroidnoduletreatment.com
2320 N. Third Street
Phoenix, AZ 85004
https://youtu.be/8Ro5jA3WQFQ?si=rzZsklsxWIsplgsS
About the Thyroid Nodule Treatment Center:
The Thyroid Nodule Treatment Center, located in Phoenix, Arizona, specializes in the diagnosis and treatment of thyroid nodules. The mission of the Thyroid Nodule Treatment Center (TNTC) is the preservation of normal thyroid function while treating benign symptomatic thyroid nodules using the most advanced minimally invasive treatments available. Under the expert leadership of Dr. Richard Harding, the center is committed to providing patients with the latest and most effective treatment options in a compassionate and supportive environment.
More on TelAve News
- Latest Updates to Pennsylvania Medical Malpractice and Birth Injury Law
- Best Plant Varieties for Windbreaks and Shelterbelts
- Genuine Hospitality, LLC Expands Leadership Team with Key Appointments
- New-and-Improved Caribbean-Food Website Dishes Out Free Ground-Shipping Offer; Affiliate Program Garnished with Generous Commission
- 50th Mount Dora Arts Festival set for Feb 1 and 2, 2024
https://thyroidnoduletreatment.center
About Dr. Richard Harding
Dr. Richard Harding treats benign symptomatic thyroid nodules using the most advance minimally invasive treatments available. Richard J. Harding, MD, FACS is the most experienced thyroid surgeon in Arizona and has been voted Top Doctor by Phoenix Magazine. He has also been awarded Surgeon of Excellence in Robotic Surgery. He has been on the forefront of surgical advances for truly scar-less surgery with his introduction of Transoral Endoscopic Thyroidectomy Vestibular Approach, the radiofrequency ablation (RFA) of benign thyroid nodules, and now CellFX nsPFA (nano-Second Pulsed Field Ablation) treatment at his state of the art facility in Phoenix, Arizona.
Source: TNTC
0 Comments
Latest on TelAve News
- Transform Warehouse Operations: Redefining Logistics with Customized Solutions
- NaturismRE Introduces Global Accreditation Standards to Redefine Nudist and Naturist Venues
- Enhancing Campus Safety for Women: The Blue Luna's New Initiative
- More high-priority SIGINT solutions were announced for Krypto1000 SIGINT software
- SCOPY.ME - Revolutionizes Business Strategy Development with AI-Powered Platform
- TimelyBill to Showcase Innovation at ITEXPO
- Moonshot Announces 6th Annual 2025 Rural Arizona Pitch Competition Tour with Bilingual Resources and Mentors
- The Dental Specialists in Newton, MA, Introduces Cutting-Edge 3Shape TRIOS 5 Intraoral Scanner
- Pikmykid Acquires Visitu to Enhance School Visitor Management Solutions
- Project EverGreen's SnowCare for Troops Program Helps Military Families Weather the Winter During Awareness Month in January
- Celebrate Love in Style: Introducing the Signature Summer Bundle for 2025 Weddings
- MileMark Explains Latest ABA Rules On Attorney Advertising
- The Annual Kingdom Day Parade Celebrates 40th Anniversary With Its " 40th Annual Kingdom Day Parade"
- Morningscore Secures $700k in Funding to Build the Next Generation of AI SEO and Expand Globally
- Certified Nutraceuticals Partners with Colorado Researchers for Groundbreaking Study on KollaJell™ and Brain Health
- GD Nationwide: 2024 Recap and 2025 Preview
- Preserving Mikaben's Legacy: A Plea For Unity And Respect
- Globally-renowned scholar Dalia Mogahed Joins Origins Consulting Group as Senior Adviser on Islamophobia
- Agreement for $27 Million in Funding for Expanding Clinic Acquisitions and Operations,: NRx Pharmaceuticals, Inc. Stock Symbol: NRXP)
- Author and Speaker El-Hajj Maurice Crawford Shabazz Releases New Book